Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $552.90M.
ENTERPRISE VALUE (EV)
$552.90M
Verastem, Inc.
Market Cap
$681.02M
Enterprise Value (EV)
$552.90M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Verastem, Inc. (VSTM) | $681.02M | $552.90M |
| Solid Biosciences Inc. (SLDB)vs › | $681.27M | $542.03M |
| Anteris Technologies Global Corp. (AVR)vs › | $685.49M | $431.42M |
| MiMedx Group, Inc. (MDXG)vs › | $673.41M | $539.07M |
| Olema Pharmaceuticals, Inc. (OLMA)vs › | $691.79M | $643.85M |
| Faeth Therapeutics, Inc. (FTH)vs › | $693.19M | $666.88M |
| Wave Life Sciences Ltd. (WVE)vs › | $693.61M | $369.19M |
| Cytek Biosciences, Inc. (CTKB)vs › | $694.79M | $647.40M |
| Helus Pharma Inc. (HELP)vs › | $666.95M | $500.78M |
| Annexon, Inc. (ANNX)vs › | $660.29M | $485.67M |
Market Cap
$681.02M
Total Debt
$76.86M
Cash
$204.99M
Enterprise Value
$552.90M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
